DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,196 filers reported holding DANAHER CORPORATION in Q4 2017. The put-call ratio across all filers is 0.78 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $522,000 | +2.6% | 3,614 | +1.5% | 0.14% | 0.0% |
Q2 2019 | $509,000 | +5.4% | 3,561 | -2.6% | 0.14% | +0.7% |
Q1 2019 | $483,000 | +19.6% | 3,657 | -6.6% | 0.14% | +3.8% |
Q4 2018 | $404,000 | -4.9% | 3,915 | 0.0% | 0.13% | +6.5% |
Q3 2018 | $425,000 | -9.8% | 3,915 | -18.0% | 0.12% | -12.1% |
Q2 2018 | $471,000 | +0.2% | 4,774 | -0.6% | 0.14% | -5.4% |
Q1 2018 | $470,000 | -46.7% | 4,805 | -49.4% | 0.15% | -46.6% |
Q4 2017 | $881,000 | +4.1% | 9,488 | -3.8% | 0.28% | -0.7% |
Q3 2017 | $846,000 | +2.9% | 9,867 | +1.2% | 0.28% | +0.7% |
Q2 2017 | $822,000 | +291.4% | 9,746 | +297.8% | 0.28% | +264.5% |
Q1 2017 | $210,000 | +5150.0% | 2,450 | +4611.5% | 0.08% | +7500.0% |
Q1 2015 | $4,000 | 0.0% | 52 | 0.0% | 0.00% | -50.0% |
Q4 2014 | $4,000 | – | 52 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
Third Point | 3,570,000 | $494,124,000 | 7.88% |